- Home
- PGYWW vs OCEAW Comparison
PGYWW vs OCEAW Comparison
Compare PGYWW & OCEAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGYWW
- OCEAW
- Stock Information
- Founded
- PGYWW 2016
- OCEAW N/A
- Country
- PGYWW United States
- OCEAW United States
- Employees
- PGYWW N/A
- OCEAW 7
- Industry
- PGYWW Finance: Consumer Services
- OCEAW Biotechnology: Pharmaceutical Preparations
- Sector
- PGYWW Finance
- OCEAW Health Care
- Exchange
- PGYWW Nasdaq
- OCEAW Nasdaq
- Market Cap
- PGYWW N/A
- OCEAW N/A
- IPO Year
- PGYWW N/A
- OCEAW 2021
- Fundamental
- Price
- PGYWW $0.20
- OCEAW $0.03
- Analyst Decision
- PGYWW
- OCEAW
- Analyst Count
- PGYWW 0
- OCEAW 0
- Target Price
- PGYWW N/A
- OCEAW N/A
- AVG Volume (30 Days)
- PGYWW 134.3K
- OCEAW N/A
- Earning Date
- PGYWW 02-13-2025
- OCEAW N/A
- Dividend Yield
- PGYWW N/A
- OCEAW N/A
- EPS Growth
- PGYWW N/A
- OCEAW N/A
- EPS
- PGYWW N/A
- OCEAW N/A
- Revenue
- PGYWW $1,032,248,000.00
- OCEAW N/A
- Revenue This Year
- PGYWW N/A
- OCEAW N/A
- Revenue Next Year
- PGYWW N/A
- OCEAW N/A
- P/E Ratio
- PGYWW N/A
- OCEAW N/A
- Revenue Growth
- PGYWW 27.12
- OCEAW N/A
- 52 Week Low
- PGYWW $0.15
- OCEAW N/A
- 52 Week High
- PGYWW $0.23
- OCEAW N/A
- Technical
- Relative Strength Index (RSI)
- PGYWW N/A
- OCEAW N/A
- Support Level
- PGYWW N/A
- OCEAW N/A
- Resistance Level
- PGYWW N/A
- OCEAW N/A
- Average True Range (ATR)
- PGYWW 0.00
- OCEAW 0.00
- MACD
- PGYWW -0.00
- OCEAW 0.00
- Stochastic Oscillator
- PGYWW 1.66
- OCEAW 0.00
About PGYWW Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, big data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.